The title compounds 1, 2, and 3 are highly effective glycosidase inhibitors. They were synthesized from achiral starting compounds by enzyme-catalyzed CC coupling of dihydroxyacetone phosphate (→ 1, 2) or hydroxypyruvate (→ 3) with racemic 3-azido-2-hydroxypropanal via fructose, sorbose and xylulose derivatives and their subsequent enantioselective catalytic hydrogenation.
No takes yet. Share an insight, caveat, or question.
Ziegler et al. (1988) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: